Key Technologies
Auckland UniServices’ intellectual horsepower is internationally recognized - the University of Auckland is ranked in the top 50 universities in the world (Times Higher Education Supplement World University ranking released in November 2007).
The organization is well connected (operating in 27 countries) and understands global business needs. Auckland UniServices’ research is curiosity-led truly proactive and innovative. We have a number of key technologies:
- Integrated Drug Discovery Expertise: 13 compounds that have entered the clinic, including 1 currently in the market and several in late stage clinical trials (for oncology, neurology and metabolic disorders).
- Medicinal Chemistry: small molecule chemistry (Prof. Bill Denny) and complex molecule chemistry (Prof. Margaret Brimble)
- Molecular Biodiscovery: clinical translational biology , structural based design of new therapeutics, Zebrafish screening (innate immune system and neurological target validation) and screening using human brain bank.
- Growth & Development (Liggins Institute): world leader in the sciences in growth and development, Liggins is researching therapeutic and nutritional interventions based on understanding how a person’s experience as a foetus affects health from birth to old age. Applications include epigenetics, neuroscience, oncology and metabolic disorders
- Clinical Research: from Phase 1 – Phase 3 Pharmaceutical Trials
Licensing Opportunities
- Anticancer Therapeutics - SN28049 (a new DNA binding anticancer compound this has a highly novel mechanism of action and a broad spectrum of experimental anti-tumour activity) Thalidomide Analogues and Small molecules targeting p53.
- Inflammatory Disorder Therapeutics - Novel peptides and peptidomimetics targeting specific integrins for inflammatory disorders.
- Anti-Microbial Wound Dressings or Coatings, a novel class of aniline copolymers that have strongly anti-microbial and anti-oxidant properties with applications in wound dressings, coatings of medical supplies, medical devices and in hospitals.
- Bone Growth Factors - Preptin, Amylin and FGF - 8
- Vaccine Technology - boosts the immune responses by conjugating the novel vaccine carrier with a weak antigen.
